Neuropsychopharmacology - Table of Contents alert Volume 39 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 39, Issue 4 (March 2014) In this issue Commentary Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Latest Neuropsychopharmacology Reviews issue The 2014 issue of Neuropsychopharmacology Reviews is entitled Biomolecular Discovery: Mechanisms, Therapeutics, and Biomarkers in Neural Disorders. The articles in this issue focus on recent advances in the detection, subtyping and monitoring of complex neural disease progression, the definition of new molecular targets for therapeutic intervention and biomarkers, with an emphasis on the use of genome-wide analytical technologies. Read the issue here  Commentary Top Acamprosate: An Alcoholism Treatment That May Not Be What We Thought Markus Heilig Neuropsychopharmacology 2014 39: 781-782; 10.1038/npp.2013.272 Full Text Original Articles Top Acamprosate Produces Its Anti-Relapse Effects Via Calcium Rainer Spanagel, Valentina Vengeliene, Bernd Jandeleit, Wolf-Nicolas Fischer, Kent Grindstaff, Xuexiang Zhang, Mark A Gallop, Elena V Krstew, Andrew J Lawrence and Falk Kiefer Neuropsychopharmacology 2014 39: 783-791; advance online publication, September 30, 2013; 10.1038/npp.2013.264 Abstract | Full Text Prenatal Tobacco Exposure and Brain Morphology: A Prospective Study in Young Children Hanan El Marroun, Marcus N Schmidt, Ingmar H A Franken, Vincent W V Jaddoe, Albert Hofman, Aad van der Lugt, Frank C Verhulst, Henning Tiemeier and Tonya White Neuropsychopharmacology 2014 39: 792-800; advance online publication, October 7, 2013; 10.1038/npp.2013.273 Abstract | Full Text Obesity at Conception Programs the Opioid System in the Offspring Brain Nicola M Grissom, Randolph Lyde, Lori Christ, Isaac E Sasson, JesseLea Carlin, Alexa P Vitins, Rebecca A Simmons and Teresa M Reyes Neuropsychopharmacology 2014 39: 801-810; advance online publication, August 8, 2013; 10.1038/npp.2013.193 Abstract | Full Text Dysregulation of Dopamine and Glutamate Release in the Prefrontal Cortex and Nucleus Accumbens Following Methamphetamine Self-Administration and During Reinstatement in Rats Aram Parsegian and Ronald E See Neuropsychopharmacology 2014 39: 811-822; advance online publication, September 2, 2013; 10.1038/npp.2013.231 Abstract | Full Text Monkeys that Voluntarily and Chronically Drink Alcohol Damage their Brains: a Longitudinal MRI Study Christopher D Kroenke, Torsten Rohlfing, Byung Park, Edith V Sullivan, Adolf Pfefferbaum and Kathleen A Grant Neuropsychopharmacology 2014 39: 823-830; advance online publication, September 27, 2013; 10.1038/npp.2013.259 Abstract | Full Text Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism Golan Karvat and Tali Kimchi Neuropsychopharmacology 2014 39: 831-840; advance online publication, October 7, 2013; 10.1038/npp.2013.274 Abstract | Full Text Simvastatin Treatment Highlights a New Role for the Isoprenoid/Cholesterol Biosynthetic Pathway in the Modulation of Emotional Reactivity and Cognitive Performance in Rats Marco Segatto, Antonia Manduca, Claudio Lecis, Pamela Rosso, Adam Jozwiak, Ewa Swiezewska, Sandra Moreno, Viviana Trezza and Valentina Pallottini Neuropsychopharmacology 2014 39: 841-854; advance online publication, October 10, 2013; 10.1038/npp.2013.284 Abstract | Full Text The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Stress-Induced Reinstatement of Opioid-Seeking in Morphine-Abstinent Mice Panos Zanos, Polymnia Georgiou, Sherie R Wright, Susanna M Hourani, Ian Kitchen, Raphaëlle Winsky-Sommerer and Alexis Bailey Neuropsychopharmacology 2014 39: 855-865; advance online publication, October 15, 2013; 10.1038/npp.2013.285 Abstract | Full Text Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET Jean-Dominique Gallezot, Tracy Kloczynski, David Weinzimmer, David Labaree, Ming-Qiang Zheng, Keunpoong Lim, Eugenii A Rabiner, Khanum Ridler, Brian Pittman, Yiyun Huang, Richard E Carson, Evan D Morris and Kelly P Cosgrove Neuropsychopharmacology 2014 39: 866-874; advance online publication, October 15, 2013; 10.1038/npp.2013.286 Abstract | Full Text Aversive Learning in Adolescents: Modulation by Amygdala–Prefrontal and Amygdala–Hippocampal Connectivity and Neuroticism Jelka Tzschoppe, Frauke Nees, Tobias Banaschewski, Gareth J Barker, Christian Büchel, Patricia J Conrod, Hugh Garavan, Andreas Heinz, Eva Loth, Karl Mann, Jean-Luc Martinot, Michael N Smolka, Jürgen Gallinat, Aandreas Ströhle, Maren Struve, Marcella Rietschel, Gunter Schumann and Herta Flor IMAGEN consortium Neuropsychopharmacology 2014 39: 875-884; advance online publication, October 15, 2013; 10.1038/npp.2013.287 Abstract | Full Text Abnormal Brain Activity During a Reward and Loss Task in Opiate-Dependent Patients Receiving Methadone Maintenance Therapy Victoria B Gradin, Alex Baldacchino, David Balfour, Keith Matthews and J Douglas Steele Neuropsychopharmacology 2014 39: 885-894; advance online publication, October 17, 2013; 10.1038/npp.2013.289 Abstract | Full Text Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat Natalia Gass, Adam James Schwarz, Alexander Sartorius, Esther Schenker, Celine Risterucci, Michael Spedding, Lei Zheng, Andreas Meyer-Lindenberg and Wolfgang Weber-Fahr Neuropsychopharmacology 2014 39: 895-906; advance online publication, October 18, 2013; 10.1038/npp.2013.290 Abstract | Full Text Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder Dawei Li, Arvis Sulovari, Chao Cheng, Hongyu Zhao, Henry R Kranzler and Joel Gelernter Neuropsychopharmacology 2014 39: 907-918; advance online publication, October 18, 2013; 10.1038/npp.2013.291 Abstract | Full Text Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression Amir Segev, Adva S Rubin, Hila Abush, Gal Richter-Levin and Irit Akirav Neuropsychopharmacology 2014 39: 919-933; advance online publication, October 21, 2013; 10.1038/npp.2013.292 Abstract | Full Text Fine Mapping on Chromosome 13q32–34 and Brain Expression Analysis Implicates MYO16 in Schizophrenia Laura Rodriguez-Murillo, Bin Xu, J Louw Roos, Gonçalo R Abecasis, Joseph A Gogos and Maria Karayiorgou Neuropsychopharmacology 2014 39: 934-943; advance online publication, October 21, 2013; 10.1038/npp.2013.293 Abstract | Full Text Altered Interhemispheric and Temporal Lobe White Matter Microstructural Organization in Severe Chronic Schizophrenia Laurena Holleran, Mohamed Ahmed, Heike Anderson-Schmidt, John McFarland, Louise Emsell, Alexander Leemans, Cathy Scanlon, Peter Dockery, Peter McCarthy, Gareth J Barker, Colm McDonald and Dara M Cannon Neuropsychopharmacology 2014 39: 944-954; advance online publication, October 22, 2013; 10.1038/npp.2013.294 Abstract | Full Text Adolescent Risk Taking, Cocaine Self-Administration, and Striatal Dopamine Signaling Marci R Mitchell, Virginia G Weiss, B Sofia Beas, Drake Morgan, Jennifer L Bizon and Barry Setlow Neuropsychopharmacology 2014 39: 955-962; advance online publication, October 22, 2013; 10.1038/npp.2013.295 Abstract | Full Text Changes in Neural Circuitry Regulating Response-Reversal Learning and Arc-Mediated Consolidation of Learning in Rats with Methamphetamine-Induced Partial Monoamine Loss Elissa D Pastuzyn and Kristen A Keefe Neuropsychopharmacology 2014 39: 963-972; advance online publication, October 22, 2013; 10.1038/npp.2013.296 Abstract | Full Text Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms Lina Chiuccariello, Sylvain Houle, Laura Miler, Robert G Cooke, Pablo M Rusjan, Grazyna Rajkowska, Robert D Levitan, Stephen J Kish, Nathan J Kolla, Xiaoming Ou, Alan A Wilson and Jeffrey H Meyer Neuropsychopharmacology 2014 39: 973-980; advance online publication, October 24, 2013; 10.1038/npp.2013.297 Abstract | Full Text Repeated Transcranial Direct Current Stimulation Prevents Abnormal Behaviors Associated with Abstinence from Chronic Nicotine Consumption Solène Pedron, Julie Monnin, Emmanuel Haffen, Daniel Sechter and Vincent Van Waes Neuropsychopharmacology 2014 39: 981-988; advance online publication, October 24, 2013; 10.1038/npp.2013.298 Abstract | Full Text CaMKII Activity in the Ventral Tegmental Area Gates Cocaine-Induced Synaptic Plasticity in the Nucleus Accumbens Xiaojie Liu, Yong Liu, Peng Zhong, Brianna Wilkinson, Jinshun Qi, Christopher M Olsen, K Ulrich Bayer and Qing-song Liu Neuropsychopharmacology 2014 39: 989-999; advance online publication, October 24, 2013; 10.1038/npp.2013.299 Abstract | Full Text Abnormal GABAergic Function and Negative Affect in Schizophrenia Stephan F Taylor, Elise Demeter, K Luan Phan, Ivy F Tso and Robert C Welsh Neuropsychopharmacology 2014 39: 1000-1008; advance online publication, October 24, 2013; 10.1038/npp.2013.300 Abstract | Full Text The Role of the Medial Prefrontal Cortex in Regulating Social Familiarity-Induced Anxiolysis Elizabeth A Lungwitz, Garret D Stuber, Philip L Johnson, Amy D Dietrich, Nicole Schartz, Brian Hanrahan, Anantha Shekhar and William A Truitt Neuropsychopharmacology 2014 39: 1009-1019; advance online publication, October 25, 2013; 10.1038/npp.2013.302 Abstract | Full Text Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia Jennifer A Hadley, Rodolphe Nenert, Nina V Kraguljac, Mark S Bolding, David M White, Frank M Skidmore, Kristina M Visscher and Adrienne C Lahti Neuropsychopharmacology 2014 39: 1020-1030; advance online publication, October 29, 2013; 10.1038/npp.2013.305 Abstract | Full Text Ammonia Mediates Methamphetamine-Induced Increases in Glutamate and Excitotoxicity Laura E Halpin, Nicole A Northrop and Bryan K Yamamoto Neuropsychopharmacology 2014 39: 1031-1038; advance online publication, October 29, 2013; 10.1038/npp.2013.306 Abstract | Full Text Corrigendum Top An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans Richard C Crist, Toni-Kim Clarke, Alfonso Ang, Lisa M Ambrose-Lanci, Falk W Lohoff, Andrew J Saxon, Walter Ling, Maureen P Hillhouse, R Douglas Bruce, George Woody and Wade H Berrettini Neuropsychopharmacology 2014 39: 1039; 10.1038/npp.2013.304 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.